ID: ALA4559160

Max Phase: Preclinical

Molecular Formula: C13H12BrN3O2S

Molecular Weight: 354.23

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COC(=O)c1sc(N/N=C/c2ccc(Br)cc2)nc1C

Standard InChI:  InChI=1S/C13H12BrN3O2S/c1-8-11(12(18)19-2)20-13(16-8)17-15-7-9-3-5-10(14)6-4-9/h3-7H,1-2H3,(H,16,17)/b15-7+

Standard InChI Key:  WNBBAOUKWJUFEG-VIZOYTHASA-N

Associated Targets(non-human)

Leucine--tRNA ligase 91 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 354.23Molecular Weight (Monoisotopic): 352.9834AlogP: 3.45#Rotatable Bonds: 4
Polar Surface Area: 63.58Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.69CX Basic pKa: 4.43CX LogP: 4.18CX LogD: 4.17
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.52Np Likeness Score: -2.12

References

1. Kovalenko OP, Volynets GP, Rybak MY, Starosyla SA, Gudzera OI, Lukashov SS, Bdzhola VG, Yarmoluk SM, Boshoff HI, Tukalo MA..  (2019)  Dual-target inhibitors of mycobacterial aminoacyl-tRNA synthetases among N-benzylidene-N'-thiazol-2-yl-hydrazines.,  10  (12): [PMID:32206244] [10.1039/C9MD00347A]

Source